Status:
UNKNOWN
Antibiotic-resistant Bacterial Infection of Hepatic Patients
Lead Sponsor:
Assiut University
Conditions:
Antibiotic Resistant Infection
Liver Cirrhoses
Eligibility:
All Genders
18+ years
Brief Summary
the investigators want to identify the microbial profile, antibiotic resistant bacteria in hepatic patients with infections in Liver ICU, and explore risk factors and outcomes in those patients with a...
Detailed Description
Bacterial infection signifies major clinical challenge in cirrhotic patients where about 35% of these patients acquire hospital-acquired infections compared with 5% of other hospital in-patients witho...
Eligibility Criteria
Inclusion
- Patients with ESLD at Liver ICU. All patients have the diagnostic criteria for liver cirrhosis by clinical, biochemical, and ultrasonography findings. The severity of liver cirrhosis will be assessed according to the Child-Pugh classification and model for end-stage liver disease (MELD) score.
- These patients are diagnosed as having infection at admission or acquire infection during hospitalization.
Exclusion
- Age ≤ 18 years
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03855709
Start Date
May 1 2019
End Date
July 1 2020
Last Update
February 27 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.